
Peter Anthopolos
Examiner (ID: 13298, Phone: (571)270-5989 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1611 |
| Total Applications | 604 |
| Issued Applications | 317 |
| Pending Applications | 63 |
| Abandoned Applications | 243 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19032382
[patent_doc_number] => 20240082197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => DELIVERY METHODS FOR OMEGA-3'S AND COMPOSITIONS FOR VITAMINS AND MINERALS USED TO ENHANCE VISUAL ACUITY AND MENTAL DEVELOPMENT IN THE HUMAN BODY
[patent_app_type] => utility
[patent_app_number] => 18/369616
[patent_app_country] => US
[patent_app_date] => 2023-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18369616
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/369616 | DELIVERY METHODS FOR OMEGA-3'S AND COMPOSITIONS FOR VITAMINS AND MINERALS USED TO ENHANCE VISUAL ACUITY AND MENTAL DEVELOPMENT IN THE HUMAN BODY | Sep 17, 2023 | Abandoned |
Array
(
[id] => 19830891
[patent_doc_number] => 20250082677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => LONG COVID MEDICATION AND METHOD OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/244569
[patent_app_country] => US
[patent_app_date] => 2023-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5110
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18244569
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/244569 | LONG COVID MEDICATION AND METHOD OF TREATMENT | Sep 10, 2023 | Pending |
Array
(
[id] => 19613016
[patent_doc_number] => 20240398696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => DELIVERY OBJECTS SUITABLE FOR NEEDLE-FREE INJECTION EQUIPMENTS
[patent_app_type] => utility
[patent_app_number] => 18/450648
[patent_app_country] => US
[patent_app_date] => 2023-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18450648
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/450648 | DELIVERY OBJECTS SUITABLE FOR NEEDLE-FREE INJECTION EQUIPMENTS | Aug 15, 2023 | Pending |
Array
(
[id] => 19232097
[patent_doc_number] => 20240189288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => TREATMENT OF GLAUCOMA USING ENDOTHELIN RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 18/345514
[patent_app_country] => US
[patent_app_date] => 2023-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18345514
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/345514 | TREATMENT OF GLAUCOMA USING ENDOTHELIN RECEPTOR ANTAGONISTS | Jun 29, 2023 | Pending |
Array
(
[id] => 18672932
[patent_doc_number] => 20230310383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING NEUROPSYCHIATRIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/206559
[patent_app_country] => US
[patent_app_date] => 2023-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18206559
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/206559 | Method of improving psychosocial health | Jun 5, 2023 | Issued |
Array
(
[id] => 18842618
[patent_doc_number] => 20230405022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => LIPID-LIKE NANOCOMPLEXES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/205096
[patent_app_country] => US
[patent_app_date] => 2023-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18205096
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/205096 | LIPID-LIKE NANOCOMPLEXES AND USES THEREOF | Jun 1, 2023 | Pending |
Array
(
[id] => 19541628
[patent_doc_number] => 20240358664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => VIGABATRIN LIQUID PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/318697
[patent_app_country] => US
[patent_app_date] => 2023-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18318697
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/318697 | Vigabatrin liquid pharmaceutical composition | May 15, 2023 | Issued |
Array
(
[id] => 18610855
[patent_doc_number] => 20230277585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => ACETIC ACID AND HYPOCHLOROUS ACID COMPOSITIONS FOR TREATMENT OF BIOFILMS AND WOUND CARE
[patent_app_type] => utility
[patent_app_number] => 18/197292
[patent_app_country] => US
[patent_app_date] => 2023-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18197292
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/197292 | ACETIC ACID AND HYPOCHLOROUS ACID COMPOSITIONS FOR TREATMENT OF BIOFILMS AND WOUND CARE | May 14, 2023 | Pending |
Array
(
[id] => 19150111
[patent_doc_number] => 11975001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one
[patent_app_type] => utility
[patent_app_number] => 18/312333
[patent_app_country] => US
[patent_app_date] => 2023-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 14059
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18312333
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/312333 | Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one | May 3, 2023 | Issued |
Array
(
[id] => 18724242
[patent_doc_number] => 20230338372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE
[patent_app_type] => utility
[patent_app_number] => 18/312375
[patent_app_country] => US
[patent_app_date] => 2023-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18312375
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/312375 | Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one | May 3, 2023 | Issued |
Array
(
[id] => 19510422
[patent_doc_number] => 20240342108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => GREEN METHOD OF PRODUCING CIRCLE-SHAPED SILVER NANOPARTICLES USING ETHYL ACETATE EXTRACT OF URTICA DIOICA LEAVES
[patent_app_type] => utility
[patent_app_number] => 18/134980
[patent_app_country] => US
[patent_app_date] => 2023-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18134980
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/134980 | GREEN METHOD OF PRODUCING CIRCLE-SHAPED SILVER NANOPARTICLES USING ETHYL ACETATE EXTRACT OF URTICA DIOICA LEAVES | Apr 13, 2023 | Pending |
Array
(
[id] => 18496123
[patent_doc_number] => 20230218667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES
[patent_app_type] => utility
[patent_app_number] => 18/122478
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18122478
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/122478 | Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses | Mar 15, 2023 | Issued |
Array
(
[id] => 19884101
[patent_doc_number] => 12269793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Affinity illudofulvene conjugates
[patent_app_type] => utility
[patent_app_number] => 18/175495
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 56
[patent_no_of_words] => 42426
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175495
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175495 | Affinity illudofulvene conjugates | Feb 26, 2023 | Issued |
Array
(
[id] => 18449382
[patent_doc_number] => 20230190658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => MAIN AGENT UNIFORMLY DISPERSED MICROSPHERE AND A SUSTAINED RELEASE FORMULATION COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/112747
[patent_app_country] => US
[patent_app_date] => 2023-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18112747
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/112747 | MAIN AGENT UNIFORMLY DISPERSED MICROSPHERE AND A SUSTAINED RELEASE FORMULATION COMPRISING THE SAME | Feb 21, 2023 | Abandoned |
Array
(
[id] => 19440007
[patent_doc_number] => 12090234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Compositions and methods related to megakaryocyte-derived extracellular vesicles
[patent_app_type] => utility
[patent_app_number] => 18/100821
[patent_app_country] => US
[patent_app_date] => 2023-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 33
[patent_no_of_words] => 49079
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18100821
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/100821 | Compositions and methods related to megakaryocyte-derived extracellular vesicles | Jan 23, 2023 | Issued |
Array
(
[id] => 18449652
[patent_doc_number] => 20230190928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => CONTROLLED RELEASE VACCINE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/154304
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18154304
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/154304 | CONTROLLED RELEASE VACCINE FORMULATION | Jan 12, 2023 | Pending |
Array
(
[id] => 18365954
[patent_doc_number] => 20230147545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => SHEET-SHAPED MEMBER
[patent_app_type] => utility
[patent_app_number] => 18/091176
[patent_app_country] => US
[patent_app_date] => 2022-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18091176
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/091176 | Sheet-shaped member | Dec 28, 2022 | Issued |
Array
(
[id] => 18339947
[patent_doc_number] => 20230131896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => COSMETIC COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/086725
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18086725
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/086725 | Cosmetic compositions and methods of use | Dec 21, 2022 | Issued |
Array
(
[id] => 18449771
[patent_doc_number] => 20230191047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => MEDICAL COUNTER MEASURES INCLUDING DRY POWDER FORMULATIONS AND ASSOCIATED METHODS
[patent_app_type] => utility
[patent_app_number] => 18/082311
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 106565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18082311
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/082311 | Medical counter measures including dry powder formulations and associated methods | Dec 14, 2022 | Issued |
Array
(
[id] => 18365926
[patent_doc_number] => 20230147517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => LIQUID FORMULATION COMPOSITIONS, MEDICAMENT DELIVERY DEVICES, AND METHODS OF PREPARATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/076012
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18076012
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/076012 | LIQUID FORMULATION COMPOSITIONS, MEDICAMENT DELIVERY DEVICES, AND METHODS OF PREPARATION AND USE THEREOF | Dec 5, 2022 | Abandoned |